Carson Wealth (CWM LLC)’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-310
Closed 4385
2022
Q3
$0 Hold
310
﹤0.01% 4307
2022
Q2
$1K Sell
310
-1,167
-79% -$1.72K ﹤0.01% 3728
2022
Q1
$3K Buy
1,477
+1,167
+376% +$2.29K ﹤0.01% 3112
2021
Q4
$1K Buy
+310
New +$1.15K ﹤0.01% 3448
2016
Q1
Sell
-310
Closed -$11K 825
2015
Q4
$11K Buy
+310
New +$20K ﹤0.01% 459

Other funds holding CLVS

Carson Wealth (CWM LLC)'s CLVS Position: Q4 2022 in Review

Carson Wealth (CWM LLC) sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 310 shares.

Carson Wealth (CWM LLC) first reported a position in CLVS in Q4 2015 and held it in 5 quarters. The position peaked at $11K in Q4 2015. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Carson Wealth (CWM LLC) reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 310 Clovis Oncology, Inc. shares in Q4 2022.
  • Carson Wealth (CWM LLC) first reported a position in Clovis Oncology, Inc. in Q4 2015 and held it in 5 quarters.
  • Carson Wealth (CWM LLC)'s Clovis Oncology, Inc. position peaked at $11K in Q4 2015.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2022, filed 1 Feb 2023.